Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
FDA Oncology Update
FDA Oncology Update
Monthly Injection Approved for Patients with Relapsed Multiple Sclerosis
Read More
FDA Oncology Update
Netspot Approved for Detection of Neuroendocrine Tumors
Read More
FDA Oncology Update
First EGFR Mutation Blood Test Approved for Patients with NSCLC
Read More
FDA Oncology Update
Atezolizumab Approved for Patients with Advanced or Metastatic Urothelial Carcinoma
Read More
FDA Oncology Update
Nivolumab Approved for Patients with Relapsed, Refractory Classical Hodgkin Lymphoma
Read More
FDA Oncology Update
Lenvatinib Approved for Use with Everolimus for Treating Advanced Renal Cell Carcinoma
Read More
FDA Oncology Update
Venclexta FDA Approved for Patients with CLL
Read More
FDA Oncology Update
FDA Approves Defitelio for Patients with Rare Disorder After HSCT
Read More
FDA Oncology Update
FDA Enhances Warnings for Serious Risks of Opioid Analgesics Abuse
Read More
FDA Oncology Update
Crizotinib Receives Expanded FDA-Approval to Treat Patients with Rare NSCLC
Read More
7
8
9
10
11
12
13
Page 10 of 13
Results 91 - 100 of 121